CIK 0001764013
- Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832771572
- Phone
- +1 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $895,852
- in 9 filings, $173K under 10b5-1 plans
Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-16 | Macias William L. Chief Medical Officer | Sale | −561 | $28.79 | $16K | 365,144 |
| 2024-10-16 | Levine Mark S. Chief Legal Officer | Sale | −2,860 | $28.79 | $82K | 327,239 |
| 2024-10-16 | Barnett Eva Renee Chief Financial Officer | Sale | −3,271 | $28.79 | $94K | 335,343 |
| 2024-10-09 | Barnett Eva Renee Chief Financial Officer | Sale | −5,162 | $29.56 | $153K | 338,614 |
| 2024-10-09 | Salzmann Peter Chief Executive Officer | Sale | −4,460 | $29.56 | $132K | 1,003,884 |
| 2024-08-21 | Levine Mark S. Chief Legal Officer | Sale | −3,164 | $31.84 | $101K | 330,230 |
| 2024-08-21 | Levine Mark S. Chief Legal Officer | Sale | −131 | $32.32 | $4K | 330,099 |
| 2024-08-21 | Macias William L. Chief Medical Officer | Sale | −2,907 | $31.84 | $93K | 368,452 |
| 2024-08-21 | Macias William L. Chief Medical Officer | Sale | −120 | $32.32 | $4K | 368,332 |
| 2024-08-21 | Barnett Eva Renee Chief Financial Officer | Sale | −3,619 | $31.84 | $115K | 343,925 |
| 2024-08-21 | Barnett Eva Renee Chief Financial Officer | Sale | −149 | $32.32 | $5K | 343,776 |
| 2024-08-21 | Butchko Julia G. Chief Development Officer | Sale | −2,907 | $31.84 | $93K | 441,079 |
| 2024-08-21 | Butchko Julia G. Chief Development Officer | Sale | −120 | $32.32 | $4K | 440,959 |
| 2024-08-21 | Salzmann Peter Chief Executive Officer | Sale | −14,470 | $31.84 | $461K | 1,008,942 |
| 2024-08-21 | Salzmann Peter Chief Executive Officer | Sale | −598 | $32.32 | $19K | 1,008,344 |
| 2024-07-24 | Stout Jay S Chief Technology Officer | Sale | −2,813 | $27.76 | $78K | 144,926 |
| 2024-07-24 | Geffner Michael Chief Medical Officer | Sale | −3,456 | $27.76 | $96K | 138,160 |
| 2024-07-24 | Levine Mark S. Chief Legal Officer | Sale | −4,015 | $27.76 | $111K | 333,394 |
| 2024-07-17 | Levine Mark S. Chief Legal Officer | Sale | −2,358 | $29.64 | $70K | 337,556 |
| 2024-07-17 | Levine Mark S. Chief Legal Officer | Sale | −147 | $30.55 | $4K | 337,409 |
Page 11 of 18 · 351 trades